Testing of combination immuno and chemoprevention strategies for lynch syndrome gastrointestinal cancer
Ended Awarded Last action
- Contract number
- HHSN26100003
- Awardee
-
Weill Medical College Of Cornell University UEI YNT8TCJH8FQ8 Part of Cornell University
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $828,445
Award facts
- Opportunity
-
- N01CN5500347 Solicitation number
- Preclinical PREVENT Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Sep 25, 2015
- Preclinical PREVENT Cancer Program for Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Jan 5, 2015
- Contract value 100% obligated
- $828,445.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- New York, NY 10021, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | -$2,779 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $151,260 | |
| Other Administrative Action | $0 | |
| Original award | $679,964 |
About this award
This federal contract award was made by the National Cancer Institute to Weill Medical College of Cornell University, a prestigious private research university, to provide services related to the testing of combination immuno and chemoprevention strategies for Lynch syndrome gastrointestinal cancer. The contract is a Delivery Order under the PREVENT Cancer Program (PREVENT) Indefinite Delivery Contract (IDC), which has a ceiling value of $149,995,000 and enables Weill Medical College to compete for task orders to deliver specialized preclinical research services to support the National Cancer Institute's mission. The specific contract award has a ceiling value of $828,445.00 and a period of performance through September 23, 2019. No set-aside designation was used for this award.
Quick answers
Who was awarded contract HHSN26100003?
HHSN26100003 was awarded to Weill Medical College Of Cornell University by National Cancer Institute (National Institutes of Health) on September 24, 2015.
How much is contract HHSN26100003 worth?
The government has obligated $828,445 on HHSN26100003.
Is contract HHSN26100003 an order under another contract?
Yes. HHSN26100003 is a delivery order under HHSN261201500039I, an indefinite delivery contract, on PREVENT Cancer Program (PREVENT).
Was contract HHSN26100003 competed?
The extent of competition for HHSN26100003 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award